Published by TMR Research Insights
Posted on August 16, 2021
4 min readLast updated: February 16, 2026
Add as preferred source on Google
Rising cases of structural heart disease are likely drive robust 7.5% CAGR in the structural heart diseases market to reach $13 bn in 2027. Rising heart diseases and growing research in structural heart diseases are expected to drive growth of the structural heart devices market.
Among the available devices in the market, the Tissue Engineered Heart Valves are expected to drive new applications in the market. These valves also known as biological valves offer new ways of replacement surgeries, which are organic and less-invasive as opposed to conventional valves. Moreover, these also offer new opportunities due to advent of personalized medicine. This segment is likely to reach US$8 bn in 2027.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54915
The structural heart devices market is expected to expand significantly in Asia Pacific region. The market promises robust opportunity in North America as large population of patients with heart disease, spread of obesity, and growing innovation will drive growth. In Asia Pacific, the rising disposable income, growing access to healthcare, and rising obesity in urban areas are expected to drive the fastest growth in the region.
Rising Heart Failure Cases to Drive New Opportunities for Growth and Innovation
The structural heart device is widely used in various cardiac procedures for acquired diseases as well as congenital diseases. These include septal defects, valvular diseases, venous obstructions, arterial diseases, and issues like atrial appendage. Among these, rising heart failure cases promise the largest application in the structural heart devices market.
Request for Analysis of COVID-19 Impact on Structural Heart Devices Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=54915
According to Center for Disease Control and Prevention, there are over 5.7 million cases of heart failure in the United States. Additionally, these amounts to 1 in 10 death cases are attributed to heart failures. CDC estimates that each year, the disease costs over $30 billion to United States government each year
Moreover, current patients with heart failure possibilities will likely face fatal consequences without the heart replacement surgeries within a 5 year period. This fatal nature, and importance of structural heart devices in treating the fatal disease is likely to create new opportunities for players in the market.
Hybrid Procedures Remain Most Promising to Drive Growth
Surgical and interventional procedures are likely to remain major applications in the structural heart devices market. Moreover, the evolution of hybrid procedures promises a robust application in the area. These include modern equipment, ventilation, and facilitation of both the procedures are important factors for end-consumers. Their cost-effective application, high imaging systematic application, and ventilation procedures will drive growth.
Buy Structural Heart Devices Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=54915<ype=S
The advancements in Computed Tomography or CT scans are also expected to create new opportunities for growth in the structural heart devices market. These are likely important for growth of catheter technologies.
More Trending Reports by Transparency Market Research –
Dermatome Devices Market: https://www.prnewswire.com/news-releases/global-dermatome-devices-market-to-reach-us-208-mn-by-2027-advances-in-skin-grafting-systems-catalyze-growth-transparency-market-research-301006420.html
Hypopigmentation Disorder Treatment Market: https://www.prnewswire.com/news-releases/growing-awareness-about-disorders-spurs-discovery-of-effective-therapeutics-in-hypopigmentation-disorder-treatment-market-topical-drugs-to-enrich-pipeline-tmr-301299862.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Transparency Market Research
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Blog: https://tmrblog.com/
Follow Us: Twitter | LinkedIn
Press Release Source: https://www.transparencymarketresearch.com/pressrelease/structural-heart-devices-market.htm
The structural heart devices market is expected to reach approximately $13 billion by 2027.
Rising cases of structural heart disease and advancements in technology are key factors driving growth in the market.
According to the CDC, there are over 5.7 million cases of heart failure in the United States, contributing to 1 in 10 death cases.
Hybrid procedures are expected to remain a promising application, driving growth and innovation in the structural heart devices market.
The Asia Pacific region is expected to expand significantly, alongside robust opportunities in North America due to a large population of patients with heart diseases.
Explore more articles in the Research Reports category
